The NAS/NAM Human Gene Editing Initiative Consensus Study Committee held an open public meeting in Washington, DC, today. The committee heard input from select stakeholder groups, including public engagement experts, affected communities, industry, and regulatory bodies. The entire meeting was filmed and is now available via video webcast. The committee’s final report is expected in late 2016.
Human Gene Editing Initiative Consensus Study Committee – Consensus Study Meeting #2
Thursday, February 11, 2016
5:00 am to 12:30 pm Pacific (8:00 am to 3:30 pm EST)
Keck Center, Room 100
500 Fifth Street NW
With the conclusion of last December’s International Summit on Human Gene Editing, the second component of the Human Gene Editing Initiative is now moving forward. The Human Gene Editing Consensus Study will convene a multidisciplinary committee of experts (including IGI Co-director Jonathan Weissman and Administrative Director Keith Yamamoto) for a comprehensive study of the scientific underpinnings of human gene-editing technologies, their potential use in biomedical research and medicine (including human germline editing) and the clinical, ethical, legal, and social implications of their use. Invited experts will discuss perspectives on human gene editing of affected communities, how public engagement intersects with science policy, and how biotech industry and regulators view the potential for developing therapeutics using human gene-editing technologies.
Over the next year, this committee will perform its own independent, in-depth review of the science and policy of human gene editing by reviewing the literature and holding data-gathering meetings in the U.S. and abroad to solicit broad input from researchers, clinicians, policymakers and the public. The committee will also monitor in real-time the latest scientific achievements of importance in this rapidly developing field.
While informed by the statement issued by the organizing committee for the International Summit on Human Gene Editing, the study committee will have broad discretion to arrive at its own findings and conclusions, which will be released in a peer-reviewed consensus report – expected to be completed in late 2016 – which will represent the official views of NAS and NAM.
We strive to make our events accessible and inclusive. The Innovative Genomics Institute Building is ADA compliant, and has a lactation room that visitors can use. For disability accommodation information and requests and/or access to the lactation room, please contact Kristy Nordahl at email@example.com or 510-664-7110.